Issued Patents All Time
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12338440 | Intracellular kinase associated with resistance against anti-tumour immune responses, and uses thereof | Antonio Sorrentino, Philipp Beckhove, Tillmann MICHELS, Nisit Khandelwal, Marco Breinig +4 more | 2025-06-24 |
| 11802285 | Cytotoxic T cell response modifiers | Philipp Beckhove, Nisit Khandelwal, Marco Breinig | 2023-10-31 |
| 10222377 | Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles | Heidi Lane, Felix Bachmann, Madlaina Breuleux, Daniel Gilbert, Xian Zhang | 2019-03-05 |
| 10065939 | Chromene derivatives and their analogs as Wnt pathway antagonists | Rajendra-Prasad Maskey, Corinna Koch, Florian Fuchs, Sandra Steinbrink, Daniel Gilbert | 2018-09-04 |
| 9994854 | Cytotoxic T cell response modifiers | Philipp Beckhove, Nisit Khandelwal, Marco Breinig | 2018-06-12 |
| 9970938 | Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles | Heidi Lane, Felix Bachmann, Madlaina Breuleux, Daniel Gilbert, Xian Zhang | 2018-05-15 |
| 9371333 | Chromene derivatives and their analoga as Wnt pathway antagonists | Rajendra-Prasad Maskey, Corinna Koch, Florian Fuchs, Sandra Steinbrink, Daniel Gilbert | 2016-06-21 |
| 9062114 | Gpr177 as target and marker in tumors | Iris Augustin | 2015-06-23 |
| 8629272 | Tricyclic pyrimidine derivatives as wnt antagonists | Florian Fuchs, Daniel Gilbert, Corinna Koch, Rajendra-Prasad Maskey, Sandra Steinbrink | 2014-01-14 |